← FDA DRUG APPROVALS

FDA ANDA · ANDA070352

DISOPYRAMIDE PHOSPHATE

Sponsor: SUN PHARM INDUSTRIES

APPLICATION
ANDA070352
TYPE
ANDA
ORIGINAL APPROVAL
1985-12-17
LATEST ACTION
1998-12-01
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

DISOPYRAMIDE PHOSPHATEDiscontinued
DISOPYRAMIDE PHOSPHATE EQ 150MG BASE · CAPSULE · ORAL

Approval history

1998-12-01Manufacturing (CMC) · Supplement 24AP
1994-12-23Manufacturing (CMC) · Supplement 23AP
1994-10-11Manufacturing (CMC) · Supplement 22AP
1992-10-15Labeling · Supplement 21AP
1992-04-03Manufacturing (CMC) · Supplement 20AP
1992-04-03Manufacturing (CMC) · Supplement 18AP
1991-11-21Labeling · Supplement 17AP
1991-09-30Labeling · Supplement 16AP
1990-08-22Labeling · Supplement 25AP
1990-08-22Labeling · Supplement 15AP
1987-12-01Manufacturing (CMC) · Supplement 12AP
1987-12-01Manufacturing (CMC) · Supplement 11AP
1987-04-01Manufacturing (CMC) · Supplement 13AP
1986-05-22Manufacturing (CMC) · Supplement 3AP
1986-05-22Manufacturing (CMC) · Supplement 10AP
1986-05-22Manufacturing (CMC) · Supplement 9AP
1986-04-08Manufacturing (CMC) · Supplement 5AP
1986-04-08Manufacturing (CMC) · Supplement 1AP
1986-04-08Manufacturing (CMC) · Supplement 6AP
1986-04-08Manufacturing (CMC) · Supplement 2AP
1985-12-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →